## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence as presented in the abstract; no access to full text, figures, tables, or supplementary materials
- **Shared manuscript claim summary** The authors report that apo-HDM2 exists in a fast-exchanging equilibrium between two closed states (closed 1 and closed 2), in addition to a previously known slow-exchanging open-closed equilibrium. They further claim that MD simulations reproduce these closed states, that chemical shift changes correspond to spatial orientations of key residues, and that S17 phosphorylation shifts the equilibrium toward closed 1, thereby suppressing p53 binding.
- **Visible evidence base** NMR analysis (chemical shift changes, exchange regimes), MD simulations (visualized conformational states), and phosphorylation experiments (S17) as described in the abstract
- **Missing materials affecting confidence** Full methods, NMR spectra and assignments, MD simulation parameters and convergence criteria, statistical analyses, structural models, and any quantitative data supporting the equilibrium shifts

## Reviewer
- **Overall assessment** The abstract presents a potentially interesting refinement of the HDM2 conformational landscape, with a plausible integration of NMR and MD approaches. However, the evidence base visible in the abstract is insufficient to evaluate the rigor of the claims, particularly regarding the assignment of two closed states, the correspondence between simulations and experiments, and the mechanistic role of S17 phosphorylation. The work may be of interest to structural biologists and cancer researchers, but the current abstract does not establish the case convincingly.
- **Who would be interested in the results, and why** Structural biologists studying intrinsically disordered proteins and conformational equilibria; computational chemists developing and validating MD methods against experimental data; cancer researchers interested in the HDM2-p53 axis as a therapeutic target, particularly regarding post-translational regulation of HDM2.
- **Major strengths** The study addresses a specific and unresolved controversy regarding S17 phosphorylation and p53 binding inhibition. The combination of NMR and MD is appropriate for characterizing conformational equilibria. The identification of a multi-state equilibrium beyond the previously known open-closed model could provide a more nuanced understanding of HDM2 regulation.
- **Major Concerns**  
  - R1-M1  
  - R1-M2  
  - R1-M3  
  - R1-M4
- **Minor Comments**  
  - R1-m1  
  - R1-m2  
  - R1-m3
- **Technical failings that need to be addressed before the case is established** R1-M1, R1-M2, R1-M3
- **Assessment against Nature-style criteria**  
  Originality: The claim of a two-closed-state equilibrium is a refinement of existing models, but the abstract does not demonstrate sufficient novelty beyond incremental extension. Scientific importance: The HDM2-p53 interaction is biologically significant, and resolving the S17 phosphorylation controversy would be valuable, but the abstract does not provide enough evidence to assess the impact. Interdisciplinary readership: The topic bridges structural biology and computational chemistry, but the abstract is written in a way that may be accessible to specialists only. Technical soundness: Cannot be evaluated from the abstract alone; key methodological details are missing. Readability for nonspecialists: The abstract is concise but assumes familiarity with NMR and MD terminology, which may limit broader accessibility.
- **Recommendation posture** Currently not established from the provided evidence. The abstract suggests a potentially valuable study, but the claims require substantial additional evidence and methodological detail to be assessed fairly.

### Major Concerns

- **Concern ID** R1-M1  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Evidence sufficiency  
- **Claim pointer** The authors claim that NMR analysis revealed a fast-exchanging equilibrium between two closed states, closed 1 and closed 2, in addition to a slow-exchanging open-closed equilibrium.  
- **Evidence pointer** Abstract, NMR analysis description; location not provided  
- **Concern** The abstract states that two closed states were identified, but no quantitative data are provided, such as population fractions, exchange rates, or chemical shift perturbation magnitudes. The distinction between closed 1 and closed 2 is not defined structurally or spectroscopically.  
- **Why it matters** Without quantitative or structural definitions, the existence of two distinct closed states cannot be distinguished from a single broad conformational ensemble or from artifacts of data fitting. This is central to the paper's main claim.  
- **Resolution test** Provide population fractions, exchange rates, and residue-specific chemical shift assignments that distinguish closed 1 and closed 2. Show that the two-state model fits the data significantly better than a one-state or continuous ensemble model.

- **Concern ID** R1-M2  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Methodological rigor  
- **Claim pointer** The authors claim that MD simulations visualized two characteristic closed states, where the spatial orientation of key residues corresponds well to the chemical shift changes of the NMR spectra.  
- **Evidence pointer** Abstract, MD simulation description; location not provided  
- **Concern** The abstract does not specify the force field, simulation length, sampling method, or convergence criteria. The correspondence between MD-derived states and NMR chemical shifts is stated qualitatively, with no metrics such as chemical shift prediction accuracy or correlation coefficients.  
- **Why it matters** MD simulations are prone to force field artifacts and insufficient sampling. A qualitative correspondence is not sufficient to validate that the simulated states represent the experimentally observed ones.  
- **Resolution test** Provide simulation details, convergence assessments, and quantitative comparison between back-calculated and experimental chemical shifts. Show that the MD-derived states are stable and reproducible across independent simulations.

- **Concern ID** R1-M3  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Causal inference  
- **Claim pointer** The authors claim that S17 phosphorylation induced an equilibrium shift toward closed 1, thereby suppressing p53 binding.  
- **Evidence pointer** Abstract, phosphorylation experiment description; location not provided  
- **Concern** The abstract asserts a causal link between phosphorylation, equilibrium shift, and functional outcome, but no binding affinity data, kinetic measurements, or control experiments are described. The direction of causality is assumed rather than demonstrated.  
- **Why it matters** The claim that phosphorylation suppresses p53 binding via a specific equilibrium shift is the key mechanistic conclusion. Without direct binding measurements or mutational controls, alternative explanations, such as direct steric interference or allosteric effects unrelated to the closed states, cannot be excluded.  
- **Resolution test** Provide binding affinity measurements for phosphorylated and unphosphorylated HDM2, and show that the equilibrium shift quantitatively accounts for the binding change. Include controls such as phosphomimetic or phosphodead mutants.

- **Concern ID** R1-M4  
- **Severity** Major  
- **Blocking** No  
- **Axis** Reproducibility  
- **Claim pointer** The study integrates NMR and MD to reveal a multi-state equilibrium of apo-HDM2.  
- **Evidence pointer** Abstract, overall study description; location not provided  
- **Concern** The abstract does not mention whether the MD simulations and NMR experiments were performed under matching conditions, such as temperature, pH, and salt concentration. It is unclear whether the observed states are condition-dependent.  
- **Why it matters** Conformational equilibria are highly sensitive to solution conditions. Mismatched conditions between experiments and simulations could lead to apparent discrepancies or false correspondences.  
- **Resolution test** State the conditions used for both NMR and MD, and demonstrate that the observed equilibrium is robust across relevant condition ranges.

### Minor Comments

- **Concern ID** R1-m1  
- **Severity** Minor  
- **Axis** Clarity  
- **Affected element** Terminology  
- **Evidence pointer** Abstract, "fast-exchanging" and "slow-exchanging" usage; location not provided  
- **Issue** The terms "fast-exchanging" and "slow-exchanging" are used without reference to the NMR timescale or the specific nuclei involved.  
- **Required correction** Define the exchange regimes in terms of chemical shift timescales, such as microseconds to milliseconds for fast exchange and milliseconds to seconds for slow exchange, with reference to the observed nuclei.

- **Concern ID** R1-m2  
- **Severity** Minor  
- **Axis** Completeness  
- **Affected element** Structural definitions  
- **Evidence pointer** Abstract, "closed 1" and "closed 2" states; location not provided  
- **Issue** The abstract does not describe what distinguishes closed 1 from closed 2 in structural terms, such as lid position, key residue contacts, or binding site accessibility.  
- **Required correction** Provide a brief structural description of each state, including the defining interactions or conformational features.

- **Concern ID** R1-m3  
- **Severity** Minor  
- **Axis** Accessibility  
- **Affected element** Abstract readability  
- **Evidence pointer** Abstract, overall text; location not provided  
- **Issue** The abstract assumes familiarity with HDM2 nomenclature and prior NMR studies, which may limit accessibility for readers outside the immediate field.  
- **Required correction** Briefly define HDM2 and the p53-binding site context, and clarify the significance of the open-closed equilibrium in one sentence.

## Risk / unsupported claims
- The existence of two distinct closed states (closed 1 and closed 2) is unsupported by quantitative data in the abstract.
- The correspondence between MD simulations and NMR chemical shifts is unquantified and therefore not assessable.
- The causal claim that S17 phosphorylation suppresses p53 binding via an equilibrium shift toward closed 1 is unsupported by binding or functional data in the abstract.
- The generalizability of the multi-state equilibrium model beyond the specific conditions used is not assessable from the abstract.